* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download Cor pulmonale - The Medical Post | Trusting Medicine
Survey
Document related concepts
Cardiovascular disease wikipedia , lookup
Management of acute coronary syndrome wikipedia , lookup
Heart failure wikipedia , lookup
Lutembacher's syndrome wikipedia , lookup
Cardiac surgery wikipedia , lookup
Myocardial infarction wikipedia , lookup
Mitral insufficiency wikipedia , lookup
Coronary artery disease wikipedia , lookup
Quantium Medical Cardiac Output wikipedia , lookup
Antihypertensive drug wikipedia , lookup
Arrhythmogenic right ventricular dysplasia wikipedia , lookup
Atrial septal defect wikipedia , lookup
Dextro-Transposition of the great arteries wikipedia , lookup
Transcript
Cor pulmonale ALOK SINHA Department of Medicine Manipal College of Medical Sciences Pokhara, Nepal Cor pulmonale is defined as an alteration in the structure and function of the right ventricle caused by a primary disorder of the respiratory system – lung parenchyma, lung vasculature or thoracic cage . Right sided heart disease secondary to lung disease Pulmonary hypertension is the common link between lung dysfunction and the heart in cor pulmonale Pathophysiology 1.Pulmonary vasoconstriction due to a.Hypoxia b.Blood acidemia 2. Obliteration of the pulmonary vascular bed secondary to lung disorders – a. emphysema b. pulmonary thrombo embolism c. interstitial lung disease 3. increased blood viscosity secondary to blood disorders polycythemia vera sickle cell disease macroglobulinemia 4. idiopathic primary pulmonary hypertension Pul art pressure – dilatation of R V – reduced C O & septal displacement-decrease L.V. volume – decresed coronary blood to R V – further detoriation of R V function Septum pushed to left Reversed Bernmeim’s effect patient with acute pulmonary hypertension due to pulmonary embolism After clot lysis Acute cor pulmonale a. massive pulmonary embolism (more common) b. acute respiratory distress syndrome (ARDS). is associated with R V dilatation Chronic cor pulmonale C O P D > 50% of cases Disorders with primary involvement of pulmonary vasculature and circulation Repeated pulmonary emboli Pulmonary vasculitis Pulmonary veno-occlusive disease Sickle cell disease High altitude disease with pulmonary vasoconstriction Primary pulmonary hypertension Disorders with secondary involvement of pulmonary vasculature and circulation Parenchymal lung diseases Chronic interstitial obstructive pulmonary diseases lung diseases Neuromuscular disorders myasthenia gravis Poliomyelitis amyotrophic lateral sclerosis Obstructive and central sleep apnea Thoracic deformities Kyphoscoliosis Ankylosing spondylitis CLINICAL FEATURES Clinical manifestations of cor pulmonale nonspecific symptoms subtle in early stages of the disease mistakenly attributed to underlying pulmonary pathology which are: Easy fatigability Tachypnea Exertional dyspnea Cough Followed by 1. Anginal chest pain Right ventricular ischemia (does not respond to nitrates) Rt. coronary artery stretching in dilated A-V groove following RVH 2. Hemoptysis because of rupture of a dilated or atherosclerotic pulmonary artery 3. A variety of neurologic symptoms may be seen due to decreased cardiac output and hypoxemia impaired cognitive & higher mental functions 4. Rarely hoarseness due to compression of the left recurrent laryngeal nerve by a dilated pulmonary artery 5. In advanced stages, passive hepatic congestion secondary to severe right ventricular failure lead to anorexia right upper quadrant abdominal discomfort jaundice 6. Syncope with exertion seen in severe disease reflects a relative inability to increase cardiac output during exercise with a subsequent drop in the systemic arterial pressure 7. Peripheral edema Physical findings may reflect a. The underlying lung disease b. pulmonary hypertension c. RVH d. RV failure On inspection 1.An increase in chest diameter 2.Laboured respiratory efforts with retractions of chest wall 3.distended neck veins with prominent “a” or giant “v” waves 4.cyanosis may be seen RVH - characterized by Epigastric pulsation left parasternal heave Apex beat: in 5th ICS outside MCL diffuse, ill suatained + Hepatojugular reflex and pulsatile liver are signs of RV failure with systemic venous congestion On percussion, hyper resonance of the lungs may be a sign of underlying COPD ascites seen in severe disease On auscultation of the chest wheezes & crackles: signs of underlying lung disease in early stages 1. Splitting of the S2 2. Loud P2 in advanced disease 1. sharp ejection click (single or multiple) over the pulmonary artery 2. Followed by ejection systolic murmur 3. Latter on: diastolic pulmonary regurgitation murmur (Graham steel) 4. may be S3 &/or S4 5. systolic murmur of tricuspid regurgitation DIFFERENTIAL DIAGNOSIS Congestive (biventricular) heart failure Primary pulmonic stenosis Primary pulmonary hypertension Right-sided heart failure due to congenital heart diseases Right heart failure due to right ventricular infarction INVESTIGATIONS Routine investigation: Hematocrit > 50 polycythemia > 60 – indication for phlebotomy To confirm diagnosis ECG X ray chest Echocardiography Right heart catheterization E C G in Cor pulomale Electrocardiography (ECG) RVH or RV strain a. right axis deviation b. R/S amplitude ratio in V1 greater than 1 R/S amplitude ratio in V6 less than 1 c. P-pulmonale -increase in P wave amplitude in leads 2, 3, and aVF d. incomplete or complete right bundle branch block (RBB), especially if pulmonary embolism is the underlying etiology e. low-voltage QRS because of underlying COPD with hyperinflation and increased AP diameter of the chest. Chest roentgenography enlargement of the central pulmonary arteries with oligemic peripheral lung fields- per. pruning right descending pulmonary artery > 16 mm left pulmonary artery >18 mm in diameter RVH Elevated brain natriuretic peptide (BNP) level Earliest evidence of CCF a natural mechanism to compensate for elevated pulmonary hypertension and right heart failure by a. promoting diuresis and natriuresis, b. vasodilating systemic and pulmonary vessels Arterial blood gas tests provide important information about the level of oxygenation and type of acid-base disorder To know the etiology P F T to confirm underlying lung disease To exclude pulmonary thromboembolism Ventilation/perfusion (V/Q) scan or CT chest Hypercoagulability states evaluated by levels of proteins C and S antithrombin III factor V Leiden antinuclear antibody (ANA) level for collagen vascular disease such as scleroderma serum alpha1-antitrypsin Oxygen therapy Diuretics Vasodilators Digitalis Anticoagulation therapy are all different modalities used in the long-term management of Chronic cor pulmonale long-term oxygen therapy can be considered even if PaO2 is greater than 55 mm Hg or O2 saturation is greater than 88%. ( because of vasodilator effect on pulmonary arteries) DIURETICS Right ventricular filling volume markedly elevated Diuretics may result in improvement of function of both the right and left ventricles adverse effects. a. Excessive volume depletion can lead to a decline in cardiac output b. hypokalemic metabolic alkalosis lead to cardiac arrhythmia Diuretics needs to be used with caution Vasodilator drugs In long-term management of chronic cor pulmonale have modest results 1.Calcium channel blockers oral sustained-release nifedipine diltiazem 2.beta blockers 3.Nitrates 4.angiotensin-converting enzyme (ACE) inhibitors not routinely used. A trial of vasodilator therapy considered in patients with COPD with disproportionately high pulmonary blood pressure – more than 40 mm Hg NEWER VASODILATORS endothelin receptor antagonist (Bosentan) prostacyclin PGI 2 analogues Epoprostenol -i.v. iloprost - M D I THEY HAVE SHOWN A PROMISING EFFECT IN REDUCING THE PULMONARY HYPERTENSION CARDIAC GLYCOSIDES NOT ROUTINELY INDICATED Beneficial effect not as obvious as in LVF modest effect of digitalis on failing right ventricle in chronic cor pulmonale Must be used cautiously should not be used during the acute phases of respiratory insufficiency Patients with hypoxemia or acidosis are at increased risk of developing arrhythmias Theophylline bronchodilatory effect reduce pulmonary vascular resistance and pulmonary arterial pressures weak inotropic effect and thus may improve right and left ventricular ejection Strenghtens diaphragm Stimulates the respiratory centre Phlebotomy Mean Pul art press and PVR decrease in polycythemic patients after phlebotomy (hematocrit of >60 or 65) The reduction of markedly elevated hematocrit level to about 50% by phlebotomy leads to 1. Reduction of blood viscosity 2. Reduction in PVR and pulmonary art pr 3. Improve gas exchange & increases exercise tolerance